Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05187351 · ClinicalTrials.gov registry record
Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions
A clinical trial of Percutaneous Coronary Intervention and Target Vessel Failure in Saphenous Vein Grafts, sponsored by Minneapolis Heart Institute Foundation.
- Active
- Registry status
- 99
- Enrollment target
- 2
- Study locations
NCT05187351 is a study of Percutaneous Coronary Intervention and Target Vessel Failure in Saphenous Vein Grafts that is active but no longer recruiting, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 99 participants, below the 5,217-participant average among 12 other Percutaneous Coronary Intervention trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05187351, a study of Percutaneous Coronary Intervention and Target Vessel Failure in Saphenous Vein Grafts, is active but no longer recruiting, sponsored by Minneapolis Heart Institute Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 99 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.
Conditions Studied
Interventions
- PROCEDURE Percutaneous coronary intervention of the native coronary artery with Synergy
Study Locations (2)
Michigan
- Henry Ford Health System - Detroit
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2021-11-21 |
| Est. Completion | 2030-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05187351
The ClinicalTrials.gov registry entry for NCT05187351 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,217-participant average among 12 other Percutaneous Coronary Intervention trials with a reported enrollment target (98% lower). The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Percutaneous Coronary Intervention appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous coronary intervention of the native coronary artery with Synergy is the first listed.
NCT05187351 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05187351 about?
NCT05187351 is a clinical study titled "Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions". The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.
What is the current status of trial NCT05187351?
This trial is currently active not recruiting. The enrollment target is 99 participants. The study started on 2021-11-21. Estimated completion is 2030-01.
What conditions does trial NCT05187351 study?
This clinical trial studies the following conditions: Percutaneous Coronary Intervention, Target Vessel Failure in Saphenous Vein Grafts.
What interventions are being tested in trial NCT05187351?
The interventions under investigation include: Percutaneous coronary intervention of the native coronary artery with Synergy (PROCEDURE).
Who is sponsoring clinical trial NCT05187351?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05187351 being conducted?
This trial has 2 study locations across Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Percutaneous Coronary Intervention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
RECRUITING · Phase 2
-
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RECRUITING · Phase 4
-
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
RECRUITING · Phase 2
-
Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
ACTIVE NOT RECRUITING · NA
-
Precision PCI Registry
ACTIVE NOT RECRUITING
-
The xDAPT External Validation Study
COMPLETED
Explore more on PlainTrial
Percutaneous Coronary Intervention
All registered trials for this condition
Target Vessel Failure in Saphenous Vein Grafts
All registered trials for this condition
Michigan
All trials with a study site in Michigan
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.